0.4948
price up icon3.10%   0.0149
after-market Handel nachbörslich: .50 0.0052 +1.05%
loading
Schlusskurs vom Vortag:
$0.4799
Offen:
$0.47
24-Stunden-Volumen:
1.10M
Relative Volume:
0.50
Marktkapitalisierung:
$46.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.54M
KGV:
-0.2499
EPS:
-1.98
Netto-Cashflow:
$-18.30M
1W Leistung:
+2.68%
1M Leistung:
+32.41%
6M Leistung:
-55.82%
1J Leistung:
-17.40%
1-Tages-Spanne:
Value
$0.451
$0.50
1-Wochen-Bereich:
Value
$0.451
$0.549
52-Wochen-Spanne:
Value
$0.202
$1.818

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name
Firmenname
Unicycive Therapeutics Inc
Name
Telefon
650-384-0642
Name
Adresse
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
UNCY's Discussions on Twitter

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-04 Eingeleitet Piper Sandler Overweight

Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten

pulisher
Oct 29, 2024

Thinking about buying stock in Beyondspring, LAVA Therapeutics, - GuruFocus.com

Oct 29, 2024
pulisher
Oct 28, 2024

Unicycive Therapeutics Delivers Multiple Poster - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024 - StockTitan

Oct 28, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024 - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

This trade activity should not be overlooked: Unicycive Therapeutics Inc (UNCY) - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY): Is Breakeven Near? - Simply Wall St

Oct 16, 2024
pulisher
Oct 15, 2024

A year in review: Unicycive Therapeutics Inc (UNCY)’s performance in the last year - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Unicycive to present kidney disease therapies at ASN Kidney Week - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Inc’s Market Journey: Closing Strong at 0.37, Up 3.12 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive to present kidney disease therapies at ASN Kidney Week By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

UNCYUnicycive Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Announces Late-Breaker Poster - GlobeNewswire

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024 - Yahoo Finance

Oct 14, 2024
pulisher
Oct 12, 2024

Unicycive Therapeutics (UNCY) Price Target Increased by 21.14% to 5.41 - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Octagon Capital Advisors LP Acquires New Stake in Unicycive Therapeutics Inc - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Octagon Capital Advisors LP Acquires New Stake in Unicycive Ther - GuruFocus.com

Oct 11, 2024
pulisher
Oct 10, 2024

H.C. Wainwright & Co. Shares Buy Rating on Biotech Co. - Streetwise Reports

Oct 10, 2024
pulisher
Oct 09, 2024

Unicycive reports successful phase 1 kidney drug trial - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Unicycive reports successful phase 1 kidney drug trial By Investing.com - Investing.com UK

Oct 09, 2024
pulisher
Oct 08, 2024

Unicycive Therapeutics Inc (UNCY) is looking forward to a strong quarter - SETE News

Oct 08, 2024
pulisher
Oct 07, 2024

UNCY’s earnings forecast for the current quarter - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

Ratio Analysis: Unpacking Unicycive Therapeutics Inc (UNCY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 07, 2024
pulisher
Oct 02, 2024

Unicycive Therapeutics Inc: Weathering Stock Market Storms with 35.62M Market Cap - The InvestChronicle

Oct 02, 2024
pulisher
Oct 01, 2024

Get in on Unicycive Therapeutics Inc’s (UNCY) buy-in window today! - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Unicycive Therapeutics' SWOT analysis: stock potential in kidney disease market - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Was anything positive for Unicycive Therapeutics Inc (UNCY) stock last session? - US Post News

Sep 30, 2024
pulisher
Sep 25, 2024

What is Unicycive Therapeutics Inc (UNCY) Stock Return on Shareholders’ Capital? - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Market Recap Check: Unicycive Therapeutics Inc (UNCY)’s Positive Finish at 0.44, Up/Down 2.82 - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - ForexTV.com

Sep 24, 2024
pulisher
Sep 24, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor - EIN News

Sep 24, 2024
pulisher
Sep 23, 2024

Unicycive Therapeutics Inc (UNCY) deserves closer scrutiny - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Unicycive Therapeutics (NASDAQ:UNCY) and Aprea Therapeutics (NASDAQ:APRE) Head to Head Comparison - Defense World

Sep 23, 2024
pulisher
Sep 19, 2024

Take off with Unicycive Therapeutics Inc (UNCY): Get ready for trading - SETE News

Sep 19, 2024
pulisher
Sep 18, 2024

Examining Unicycive Therapeutics Inc (UNCY) more closely is necessary - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

Three Central African countries commit to global eradication of Guinea-worm disease - WHO | Regional Office for Africa

Sep 18, 2024
pulisher
Sep 17, 2024

Upward Trajectory: Unicycive Therapeutics Inc (UNCY) Posts a Slidee, Closing at 0.38 - The Dwinnex

Sep 17, 2024
pulisher
Sep 16, 2024

Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024 - StockTitan

Sep 16, 2024
pulisher
Sep 15, 2024

Uxin finds new friend on difficult road to profitability - Bamboo Works

Sep 15, 2024
pulisher
Sep 14, 2024

ICMR partners with industry leaders for groundbreaking First-in-Human Phase-1 clinical trials - ETHealthWorld

Sep 14, 2024
pulisher
Sep 11, 2024

Views of Wall Street’s Leading Experts on Unicycive Therapeutics Inc - SETE News

Sep 11, 2024
pulisher
Sep 11, 2024

Unicycive Therapeutics Inc’s Market Journey: Closing Strong at 0.39, Up 5.51 - The Dwinnex

Sep 11, 2024
pulisher
Sep 10, 2024

Unicycive Therapeutics Inc (UNCY) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Sep 10, 2024
pulisher
Sep 09, 2024

Unicycive Therapeutics Inc’s results are impressive - US Post News

Sep 09, 2024
pulisher
Sep 06, 2024

Unicycive stock remains Speculative Buy-rated by Benchmark; optimistic on FDA submission - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Unicycive Therapeutics Inc (UNCY) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

Sep 05, 2024
pulisher
Sep 05, 2024

There is no way Unicycive Therapeutics Inc (UNCY) can keep these numbers up - SETE News

Sep 05, 2024
pulisher
Sep 05, 2024

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - The Bakersfield Californian

Sep 05, 2024
pulisher
Sep 05, 2024

Shilpa Medicare announces submission of NDA for Oxylanthanum Carbonate to USFDA by Unicycive Therapeutics - Medical Dialogues

Sep 05, 2024
pulisher
Sep 04, 2024

Unicycive retains Buy rating, stock target post-NDA submission By Investing.com - Investing.com Canada

Sep 04, 2024

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):